SYS ONLINE
Supplements/Amino Acid

NAC (Lung Support)

Mucolytic and antioxidant — used for COPD exacerbations and idiopathic pulmonary fibrosis.

Buy

Overview

Mucolytic and antioxidant — used for COPD exacerbations and idiopathic pulmonary fibrosis.

Natural sources
  • Dietary protein from animal sources (meat, fish, eggs, dairy) and plant sources (soy, legumes, grains)
  • Free-form amino acid powders and capsules
  • Targeted pre-workout, recovery, or sleep formulations
Common forms
  • Free-form crystalline powder
  • Capsules or tablets
  • Pre-mixed recovery or hydration beverages
  • Time-release formulations

Mechanism of action

Breaks disulfide bonds in mucus; replenishes pulmonary glutathione.

Pathways
  • · Breaks disulfide bonds in mucus
  • · replenishes pulmonary glutathione

Effects on the body

Decreases
COPD exacerbations

Organ system effects

Evidence-based benefits

Reduces COPD exacerbations

Moderate evidence

Potential side effects

Common
  • · Sulfur burps
Rare
    Serious

      Drug interactions

      Prescription medications (general)
      Always disclose NAC (Lung Support) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
      minor

      Supplement interactions

      Pairs well with
      • A high-quality multivitamin
        Covers micronutrient cofactors that support most supplement pathways.
      • Omega-3 (EPA/DHA)
        Foundational anti-inflammatory support that complements most regimens.
      Avoid combining with

      No specific avoidances listed.

      Dosing & bioavailability

      Typical dose
      600 mg BID-TID
      Best form
      Most evidence is based on the free-form crystalline powder form.
      Timing
      Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
      With food?
      Optional

      Where to buy

      Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

      Scientific evidence8Show studies
      RCTLancet Respir Med · 2014

      NAC in chronic obstructive pulmonary disease (PANTHEON)

      Zheng JP, et al.

      1-year RCT of NAC 600 mg BID in COPD.

      Key findings

      Reduced exacerbation rate by 22%.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: NAC (Lung Support) — Reduces COPD exacerbations

      Live PubMed search

      Live results for "NAC (Lung Support) Reduces COPD exacerbations" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching NAC (Lung Support) and "Reduces COPD exacerbations". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: NAC (Lung Support) — randomized controlled trial

      Live PubMed search

      Live results for "NAC (Lung Support) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching NAC (Lung Support) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: NAC (Lung Support) — meta-analysis

      Live PubMed search

      Live results for "NAC (Lung Support) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching NAC (Lung Support) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: NAC (Lung Support) — pharmacokinetics

      Live PubMed search

      Live results for "NAC (Lung Support) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching NAC (Lung Support) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: NAC (Lung Support) — safety adverse events

      Live PubMed search

      Live results for "NAC (Lung Support) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching NAC (Lung Support) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: NAC (Lung Support) — dose response

      Live PubMed search

      Live results for "NAC (Lung Support) dose response" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching NAC (Lung Support) and "dose response". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewGoogle Scholar · 1970

      Google Scholar: NAC (Lung Support) — clinical evidence

      Live Scholar search

      Cross-database citation index for NAC (Lung Support) as it relates to "clinical evidence".

      Key findings

      Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

      Open study
      Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

      Community discussion

      (0 threads)

      Share your experience or read what others have tried. Anecdotes are not medical advice.

      Sign in or create a free account to post or reply.
      Loading discussion…